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RNA binding proteins (RBPs) have emerged as major
causative agents of amyotrophic lateral sclerosis
(ALS). To investigate the function of TAF15, an RBP
recently implicated in ALS, we explored its target
RNA repertoire in normal human brain and mouse
neurons. Coupling high-throughput sequencing of
immunoprecipitated and crosslinked RNA with RNA
sequencing and TAF15 knockdowns, we identified
conserved TAF15 RNA targets and assessed the
impact of TAF15 on the neuronal transcriptome. We
describe a role of TAF15 in the regulation of splicing
for a set of neuronal RNAs encoding proteins with
essential roles in synaptic activities. We find that
TAF15 is required for a critical alternative splicing
event of the zeta-1 subunit of the glutamate
N-methyl-D-aspartate receptor (Grin1) that controls
the activity and trafficking of NR1. Our study
uncovers neuronal RNA networks impacted by
TAF15 and sets the stage for investigating the role
of TAF15 in ALS pathogenesis.
INTRODUCTION
RNA binding proteins (RBPs), of which heterogeneous nuclear
ribonucleoproteins (hnRNPs) constitute a major class, are multi-
functional proteins that are involved in numerous aspects of RNA
processing and function (Dreyfuss et al., 2002). Amyotrophic
lateral sclerosis (ALS) is a fatal disease caused by degeneration
of motor neurons. In 20% of cases, ALS is part of a broader
neurodegenerative disease spectrum that includes frontotem-
poral lobar degeneration (FTLD) (Ibrahim et al., 2012; Mackenzie
and Neumann, 2012). Dominant mutations in genes coding for
four hnRNPs (TDP-43, FUS/TLS, TAF15, and EWS) are found
in familial and sporadic cases of ALS (Couthouis et al., 2011,
2012; Neumann et al., 2006; Ticozzi et al., 2011; Vance et al.,C2009). RBPs that cause or are associated with ALS and FTLD
have prion-like domains that under pathological conditions
promote their aggregation (Ibrahim et al., 2012; Johnson et al.,
2008; King et al., 2012).
N-methyl-D-aspartate receptors (NMDARs) are ionotropic
glutamate receptors with central roles in excitatory synaptic
activities and neuronal development (Dingledine et al., 1999;
Lau and Tymianski, 2010; Paoletti, 2011). NMDAR is a hetero-
meric complex composed of two obligatory NR1 subunits and
two NR2 subunits (NR2A-2D) (Be´he´ et al., 1995; Dingledine
et al., 1999). The NR1 subunit (also known as zeta-1) is encoded
by theGrin1 gene and is required for the formation and regulation
of functional receptors (Moriyoshi et al., 1991; Paoletti, 2011).
Grin1 undergoes differential mRNA splicing to create different
isoforms of NR1 subunits that contain distinct regulatory
elements within their C-terminal tails including the C1 cassette
(Dingledine et al., 1999). The C1 domain, encoded by E19 exon
ofGrin1, plays critical roles in regulation of NR1 function and traf-
ficking and is subjected to activity-dependent regulation (re-
viewed in Li et al., 2007). Phosphorylation of C1 cassette poten-
tiates NMDA activity and trafficking (Hisatsune et al., 1997).
Activation of NMDAR enhances calcium influx and intracellular
Ca+2/calmodulin binding (Ehlers et al., 1996; Lan et al., 2001;
Okabe et al., 1999; Tingley et al., 1997). CaM binding at the C1
cassette underlies NMDAR-dependent plasticity and protect
against excitotoxic cell death (Ehlers et al., 1996).
TAF15 along with FUS and EWS belongs to the FET family of
RBPs (Bertolotti et al., 1996). All of the FETmembers are involved
in various aspects of RNA metabolism and are predominantly
nuclear. Recently, putative ALS causing mutations were
described in the TAF15 gene in familial (Ticozzi et al., 2011)
and sporadic cases (Couthouis et al., 2011). Similar to TDP-43
and FUS proteinopathies, the sporadic ALS-associated variants
of TAF15 (i.e., R408C) caused formation of cytoplasmic aggre-
gates in cultured neurons and neurodegeneration in Drosophila
(Couthouis et al., 2011). TAF15 cytoplasmic inclusions are also
found in all cases of FUS-FTLD subtypes, further strengthening
the notion of a pathogenic role of TAF15 in neurodegeneration
(Neumann et al., 2011). TDP-43 and FUS RNA interactionell Reports 3, 301–308, February 21, 2013 ª2013 The Authors 301
Figure 1. TAF15 HITS-CLIP of Human
Brains and Mouse Neurons
(A) HITS-CLIP schematic.
(B) TAF15 CLIPs from three human brains. Lines
(black; 1L, 2L, and 3L, red; 2H and 3H) indicate
TAF15-RNA complexes that were excised for
library preparation. NRS; nonimmune serum
(negative control).
(C) Screen shot from UCSC Genome Browser of
portion of human Gria2 gene (chr4: 158,255,078–
158,257,088) with TAF15 peaks.
(D) Distribution of human brain CLIP-tag peaks.
(E) TAF15 CLIPs from cultured mouse neurons.
(F) Distribution of mouse neuron CLIP-tag peaks.
(G) Overlap between top human andmouse TAF15
RNA targets.
See also Figures S1, S2, and S3.maps have begun to address their impact on neuronal RNA pro-
cessing (Ishigaki et al., 2012; Lagier-Tourenne et al., 2012; Poly-
menidou et al., 2011).
TAF15 has been implicated in pre-mRNA splicing (Hoell et al.,
2011; Jobert et al., 2009), but the neuronal RNA targets of TAF15
and the impact of TAF15 on the neuronal transcriptome are not
known. Here, we report the in vivo RNA targets of TAF15 in
human brain and mouse neurons, and we define conserved
groups of neuronal TAF15 targets that implicate TAF15 in the
control of mRNAs that code for proteins with essential roles in
synaptic activities. We find that TAF15 is required for a critical
alternative splicing event ofGrin1 E19 exon that controls the traf-
ficking of NMDA glutamate receptor. Our study uncovers
neuronal RNA networks impacted by TAF15 and sets the stage
for investigating the role of TAF15 in ALS and FTLD
pathogenesis.
RESULTS AND DISCUSSION
TAF15-RNA InteractionMaps inHumanBrain andMouse
Neurons
We employed high-throughput sequencing of immunoprecipi-
tated and crosslinked RNA (HITS-CLIP) (Chi et al., 2009) (Fig-
ure 1A) to identify in vivo RNA targets of TAF15 from three302 Cell Reports 3, 301–308, February 21, 2013 ª2013 The Authorsunrelated, normal human brains. CLIPs
of TAF15 from human brains resulted in
the formation of specific complexes of
TAF15 with RNAs, which were absent in
the nonimmune rabbit serum (NRS) lane
(Figures 1B and S1A–S1C; Extended
Results). We prepared libraries from the
membrane segments containing the
main radioactivity signal (1L, 2L and 3L)
and from the portions of the membrane
just above the main signal in brains 2
and 3 (2H and 3H) (Figure 1B). Attempts
to generate cDNA libraries from the
NRS-negative control failed indicating
the stringency of our CLIPs. The five brain
TAF15 CLIP libraries generated a total of23.9 million reads that mapped to the human genome (hg19).
The majority of the reads (90%) mapped in gene’s sense
strands. We did not find any correlation between TAF15 binding
and RNA expression levels (Extended Results), indicating that
peaks containing abundant TAF15 CLIP tags represent substan-
tial TAF15 RNA binding sites and do not merely correlate with the
abundance of the targeted transcripts.
To verify the reproducibility and significance of the computa-
tional analyses, the bioinformatics were performed for each
CLIP sample independently; all conclusions were consistent
for all CLIP samples. Genomic positions of TAF15 peaks were
highly consistent in all five libraries prepared from the three
human brains (Figures 1C and S2A; Extended Results). We
used peaks calling to analyze the CLIP-tag distribution, and we
found that 58% of the peaks mapped to introns, 4% to
coding exons, 4% to 30 UTRs and 1% to 50 UTRs, indicating
that TAF15 binds predominantly to pre-mRNAs, which is consis-
tent with the nuclear localization of TAF15 (Figure 1D). A sizable
portion of the peaks mapped to intergenic regions (36%)
implying possible TAF15 binding to noncoding RNAs and nonan-
notated transcripts (Figure 1D).
To uncover transcripts that are likely to be functionally regu-
lated by TAF15, we sought to identify conserved TAF15 binding
sites by performing HITS-CLIP in mouse neurons that we
Table 1. Gene Ontology Term Analysis for Top, Conserved, Human, and Mouse TAF15 RNA Targets Identified by CLIP
Gene Ontology Category GO Term Description p Value
Molecular function GO:0008066 glutamate receptor activity 3.51 3 10007
GO:0005216 ion channel activity 1.12 3 10006
GO:0004970 ionotropic glutamate receptor activity 1.24 3 10006
GO:0004872 receptor activity 1.90 3 10006
GO:0005234 extracellular-glutamate-gated ion channel activity 2.06 3 10006
Cellular component GO:0005886 plasma membrane 2.03 3 10013
GO:0030425 dendrite 1.32 3 10008
GO:0014069 postsynaptic density 1.88 3 10008
GO:0043025 neuronal cell body 9.17 3 10008
GO:0030424 axon 1.08 3 10007
GO:0045202 synapse 2.12 3 10007
GO:0016020 membrane 1.12 3 10006
GO:0030288 outer membrane-bounded periplasmic space 1.24 3 10006
GO:0045211 postsynaptic membrane 3.43 3 10006
GO:0043198 dendritic shaft 3.66 3 10006
GO:0031225 anchored to membrane 5.01 3 10006
GO:0043195 terminal button 5.57 3 10006
GO:0030054 cell junction 8.16 3 10006
Biological process GO:0007155 cell adhesion 3.53 3 10008
GO:0007215 glutamate signaling pathway 3.51 3 10007
GO:0007158 neuron cell-cell adhesion 6.96 3 10007
GO:0007268 synaptic transmission 2.51 3 10006
GO:0050804 regulation of synaptic transmission 4.77 3 10006
GO:0060079 regulation of excitatory postsynaptic membrane potential 9.50 3 10006differentiated from embryonic stem cells (ESCs) (Figure S1D).
We performed two biological replicates of TAF15 HITS-CLIP
(Figure 1E; Extended Results) and generated a total of
24.3 million reads that were mapped to the mouse genome
(mm9) with the majority of reads (94%) corresponding to sense
strands of genes. Peaks were defined as for human CLIPs. The
genomic distribution of mouse TAF15 peaks was similar to that
of human CLIP and showed predominant binding of TAF15 to
mouse introns (70%; Figure 1F). Assessment of TAF15 peaks
for lincRNA bindings revealed a mean of less than 3% binding
in human and mouse libraries. Consistent with our findings,
PAR-CLIP of overexpressed FLAG-tagged TAF15 in HEK293
cells revealed a large fraction of clusters within intronic regions
(Hoell et al., 2011). However, our study probes the binding sites
of endogenous TAF15 in the context of normal mouse neurons
and human brain, which is more relevant to the function of
TAF15 in neural tissue and applicable to future studies related
to ALS and FTLD.
To examine TAF15 sequence specificity, we extensively
searched for enriched Nmers (4-mer to 7-mer) within human
and mouse TAF15 CLIP tags (Table S1). As expected, we
observed an increase of Nmer abundance for shorter Nmers.
However, consistent with the observation that RBPs bind to
degenerate sequences and their binding is influenced by RNP
complexes that they associate with (Dreyfuss et al., 2002), we
found that even the most enriched Nmer accounts for less thanC30% of CLIP tags. This is consistent with PAR-CLIP of FLAG-
tagged TAF15 in HEK293 cells, which uncovered no significant
motif (Hoell et al., 2011). Interestingly, clustering of the top 20
6-mer using the Bayesian Likelihood 2-Component metric
(Habib et al., 2008) revealed a cytosine-uridine-guanine prefer-
ence suggesting a possible binding specificity.
TAF15 Targets Genes with Synaptic Activities
To identify the most consistently targeted human and mouse
RNA transcripts, we ranked genes that contained TAF15 peaks
using the rank product of the number of CLIP tags in all CLIP
experiments (pfp < 0.1). We identified 367 human genes (with
mouse homologs) and 129 mouse genes that were consistently
targeted by TAF15 (Table S2). The higher number of targets
identified in the human samples is expected because of the
cellular heterogeneity of human brain that contains various
types of neurons and glial cells, compared to the mouse
samples, which represent highly pure neurons. Notably, of the
highly TAF15 targeted mouse transcripts 74% are the same
in humans (Figure 1G), indicating the presence of a conserved
network of neuronal RNAs that are targeted by TAF15. Gene
ontology (GO) term analysis (Table 1) revealed enrichment of
genes involved in synaptic structure, function, and transmission
such as subunit zeta-1 of the NMDA receptor (NR1, NMDAR1,
Grin1); subunits 2A and 2B of the NMDAR (NR2A, Grin2a;
NR2B, Grin2b); potassium voltage-gated channel subfamily Dell Reports 3, 301–308, February 21, 2013 ª2013 The Authors 303
member 2 (Kcnd2); subunits 2 and 4 of the ionotropic AMPA
glutamate receptor (Gria2, Gria4); neurexin 1 and 3 (Nrxn1,
Nrxn3); neuroligin 1 (Nlgn1); and protocadherin-9 (Pcdh9). GO
term analysis of TDP-43 after depletion revealed enrichment
of targets with synaptic activities (Polymenidou et al., 2011).
Notably, comparing the highly targeted TAF15 mouse RNA
transcripts to those of FUS (Lagier-Tourenne et al., 2012) re-
vealed that 146/164 (89%) of TAF15 targets are also targeted
by FUS (Table S3; Figure S3A; Extended Results), indicating
that the two RBPs possibly regulate common neuronal
networks.
The Impact of TAF15 in the Transcriptome of Mouse
Neurons
To explore the role of TAF15 in the mouse neuronal transcrip-
tome, we analyzed changes in levels and splicing patterns of
RNAs upon depletion of TAF15 by performing control (CTRL)
and TAF15 small interfering RNA (siRNA) knockdowns (KD) (Fig-
ure S1D) in biological triplicates. We achieved a75% reduction
of TAF15 mRNA (Figure 2A) and protein levels (Figure 2B). Using
RNA sequencing (RNA-seq) (Vourekas et al., 2012), we gener-
ated six libraries (three CTRL and three KD) and obtained a total
of 89.0 and 72.5 million reads from CTRL and KD libraries,
respectively, that mapped to the mouse genome. Comparisons
of the mRNA expression levels between CTRL and KD RNA-seq
libraries identified 92 protein-coding genes with reduced
expression and 87 protein-coding genes with increased expres-
sion upon TAF15 knockdown (Figure 2C; Table S4). The few
changes in the levels of mRNAs, overall, suggest that TAF15
has no global effect on the stability of mRNAs. At this point, it
is not clear how TAF15 impacts on the levels of these
transcripts.
To address the impact of TAF15 in pre-mRNA splicing, we
compared exon expression levels between CTRL and TAF15
KD. We identified 958 unique exons of protein-coding genes
with significantly (p < 0.01) reduced expression (exon exclu-
sion), and 827 unique exons with significantly (p < 0.01)
increased expression (exon inclusion) upon TAF15 knockdown
(Figure 2D, Table S4). We validated by PCR randomly selected
exons from Table S4 containing TAF15 CLIP tags in their vicinity
and whose inclusion was either inhibited (pericentriolar material
1 [Pcm-1]; integrin-linked kinase-associated serine/threonine
phosphatase 2C [Ikap]; myelin transcription factor 1 isoform
4 [Myt1]; and Slit homolog 1 protein precursor [Slit1]) or
promoted (serine/threonine-protein kinase RIO2 [Riok2]; pro-
teasomal ubiquitin receptor [Adrm1]; myelin expression factor
2 isoform 3 [Myef2]; cAMP-dependent protein kinase catalytic
subunit [Prkacb]; and RB1-inducible coiled-coil protein 1
[Rb1cc1]) upon TAF15 knockdown (Figure 2E). We did not
detect correlation between the position of TAF15 peaks and
the direction of splicing changes (exon inclusion or exclusion).
However, we note that the impact of TAF15 in splicing is likely
more widespread than the one uncovered by the RNA-seq
experiments because of the stringent criteria that we used to
define changed exons and limitations of RNA-seq (Ozsolak
and Milos, 2011).
We tested some of the top targeted TAF15 genes that are
associated with neurological disorders including Frmd4a304 Cell Reports 3, 301–308, February 21, 2013 ª2013 The Authors(FERM domain-containing protein 4a isoform 1), Cacna1c
(voltage-dependent L-type calcium channel subunit), and
Pcdh9 (Protocadherin-9). We also tested Sod1 (superoxide dis-
mutase Cu-Zn), which is mutated in a subset of familial ALS
cases. RT-PCR analyses after TAF15 knockdown in mouse
neurons revealed marked reduction of Pcdh9, mild reduction
of Frmd4a, and Cacna1c but no changes in the levels of
Sod1 suggesting a role for TAF15 in the regulation of these
transcripts (Figure S3B). Knockdown of TAF15 did not alter
the levels of TDP-43 or FUS (Figure S3C); however, we note
the limitation of this analysis, which is confined to neurons in
culture.
As noted from the TAF15 CLIP assays in both human and
mouse, there was high overlap in TAF15 targets that regulate
synaptic activities and functions. We examined a set of targets
within this category, which contain differentially regulated exons
(p < 0.05) and also harbor TAF15-binding sites in a 2 kb distance
up- or downstream of the changed exon. Out of these targets,
we validated Grin2a, Grin2b, Gria2, Gria4, and gamma-amino-
butyric acid receptor subunit beta-3 (Gabrb3) and observed
reduction of exon inclusion upon depletion of TAF15 among all
the genes (Figure S4A). To further explore the effect of TAF15
on those targets, we analyzed mouse cultured neurons express-
ing FLAG-tagged TAF15 wild-type and TAF15-R408C (a recently
identified ALS variant; Couthouis et al., 2011) (Figure S4B).
RT-PCR analyses revealed a reduction of exon inclusion of
Grin2b, Gria2, and Gabrb3 and a slight increase of exon inclu-
sion of Grin2a and Gria4 in cells expressing TAF15-R408C
compared to controls (Figure S4C). These results suggest
a role of TAF15 and the ALS variant (R408C) in regulating targets
with synaptic activities and support future investigations to
address mechanistically how the levels of TAF15 and the ALS
variant affect splicing and the neuronal transcriptome, which
currently is unknown.
TAF15 Regulates Inclusion of the C1 Cassette of NR1
Receptor
We noticed TAF15 binding sites near the E19 exon, coding for
C1 cassette, of both human and mouse Grin1 of NMDAR
(Figures 3A and 3B) and sought to identify the impact of
TAF15 in the regulation of splicing of E19 by performing
PCRs in mouse neurons depleted of TAF15. We found an
increase of Grin1 transcripts lacking E19 and concomitant
decrease of transcripts that harbor E19 (Figure 3C) upon
TAF15 knockdown, indicating that TAF15 promotes inclusion
of E19. NMDAR play a crucial role in the central nervous system
(Dingledine et al., 1999; Ehlers et al., 1996) and misregulation of
this receptor is relevant to several neurodegenerative disorders
including ALS (Plaitakis and Caroscio, 1987; Texido et al.,
2011).
We set out to test the effect of E19 exclusion after TAF15
depletion using both mouse neurons and importantly primary
rat cortical neurons that have been used extensively to study
NMDAR regulation and function (Williams et al., 1992). We es-
tablished efficient TAF15 knockdowns in rat cortical neurons
(Figure 3D). We used an antibody that recognized all NR1 iso-
forms to perform immunoprecipitations (IPs) from CTRL and
TAF15 KD and probed the IPs with an antibody that recognizes
Figure 2. Impact of TAF15 Knockdown on
the Transcriptome of Mouse Neurons
(A and B) TAF15 mRNA (A) and protein levels (B)
after siRNA knockdown of TAF15 (KD), compared
to control knockdown (CTRL), in mouse neurons.
Quantitations (A and B) are shown as mean ± SD,
from three biological replicates; changes are
significant (p < 0.01).
(C and D) Scatterplot of genes (C) and exons (D)
expression calculated by RNA-seq from three KD
and three CTRL samples. Differentially expressed
genes and exons (n = 3; p < 0.01) are highlighted,
glog; generalized logarithm base 2.
(E) RT-PCR validations of differentially included
exons in mRNAs whose levels did not change
upon TAF15 knockdown. Shown are schematics
(constitutive exon: black box; differentially
included exon: red box; intron: black line) with
primers (arrows) and position of TAF15-peaks
(blueboxes).Quantitation (error bars represent SD)
and representative gels from RT-PCRs are shown.
All detected changes are significant (p < 0.01).
See also Figures S2 and S3.full-length NR1 or NR1 containing the C1 cassette. The overall
levels of NR1 were similar between CTRL and TAF15 KD;
however, we detected a 60% reduction of NR1 receptors con-
taining the C1 cassette in TAF15 KD (Figure 3E) and a 40%
reduction of the phosphorylation level of NR1 subunit inCell Reports 3, 301–308,TAF15 depleted neurons (Figure 3F),
consistent with the reduction of NR1
receptors containing the C1 cassette
that is subject to phosphorylation.
Calmodulin-agarose pull-downs and
immunoblots for NR1 revealed a 40%
reduction of CaM-bound NR1 in TAF15
KD again consistent with reduction of
NR1 receptors containing the C1
cassette that binds to CaM (Figure 3G).
To further explore the effect of C1 reduc-
tion on targeting of NR1, we used a cell
surface biotinylation assay to test the
amount of NR1 that associates with
plasma membranes. We detected
25% reduction of the cell surface NR1
in cells depleted of TAF15 compared to
CTRL (Figure 3H). Collectively, our
observations suggest a role of TAF15 in
regulating the splicing of E19, which
may alter receptor trafficking (Figure 3I).
Because NMDAR-dependent neuro-
transmission is affected by changes in
receptor trafficking, gating, and alterna-
tive RNA splicing of Grin1 isoforms, mis-
regulation of these activities is relevant
to several neurodegenerative disorders,
including ALS (Plaitakis and Caroscio,
1987; Milnerwood et al., 2010; Spalloniet al., 2013). Our findings emphasize the importance of NMDAR
regulation, and more generally, the discovery of human and
mouse neuronal RNA targets of TAF15 will facilitate future
investigations into the role of TAF15 in ALS and FTLD
pathogenesis.February 21, 2013 ª2013 The Authors 305
Figure 3. TAF15 Regulates Receptor Prop-
erties of NR1 via Alternative Splicing of
Exon 19 of Grin1
(A) Peptide sequence of C1 cassette of NR1 en-
coded by E19 of Grin1 with serine 896/897 resi-
dues that are subjected to phosphorylation and
the calmodulin binding site (amino acids in blue);
the C1 sequence is 100% conserved in humans,
mouse and rat.
(B) Screen shot from UCSC Genome Browser of
portion of human (top) and mouse (bottom) Grin1
gene, coding for NMDAR NR1 subunit zeta-1
(NR1; NMDAR1) with alternative E19 (red box) and
location of TAF15 CLIP tags (blue boxes).
(C) TAF15 promotes inclusion of E19/C1 of mouse
Grin1. PCR analyses of Grin1 with E18/20 (top)
and E19/20 specific primers (bottom). A significant
reduction in E19 inclusion was detected in TAF15
knockdowns (KD) compared to control knock-
downs (CTRL). Quantitation and representative
gels from RT-PCRs are shown.
(D–I) Impact of TAF15 on NR1 receptor of rat
cortical neurons. All experiments were performed
in triplicates from TAF15 knockdowns (KD) and
controls (CTRL); error bars in (E)–(H) represent SD;
all detected changes are significant (p < 0.05). (D)
TAF15 protein levels after siRNA knockdown of
TAF15. (E) NR1 immunoprecipitates were im-
munoblotted (IB)with anantibodydetectingall NR1
protein isoforms (NR1) or detecting specifically the
C1 cassette (NR1-C1; left). Quantitation from three
experiments is shown. (F) Neuronal lysates were
immunoblotted with an antibody detecting phos-
pho-S896/897 NR1 and normalized to GAPDH. (G)
Calmodulin-agarose pull-downs were probed by
immunoblots for NR1. (H) Cell surface biotinylation
(experimental schematic, left panel) of rat cortical
neurons after TAF15 CTRL or KD for detection of
NR1 that associates with plasma membranes;
quantitation from three experiments is shown (right
panel). (I) Schematic of TAF15 impact on NR1
function via splicing regulation of E19.
See also Figure S4.EXPERIMENTAL PROCEDURES
Cell Culture
Mouse ESCs were maintained in ESC medium on gelatinized plates without
feeder cells. Neuronal differentiation was performed as described previously
(Wichterle et al., 2009). Cells were maintained into ADFNB+GDNF. Primary rat
cortical neurons were prepared and cultured as previously described (Dichter,
1978). Cells weremaintained into Neurobasalmedium supplementedwith B27.
HITS-CLIP and Solid Support Directional RNA-Seq
Studies conducted with human specimens were approved by the University of
Pennsylvania Institutional Review Board. The three human brains consisted of
fresh temporal cortices containing live cells (neurosurgical specimens). HITS-
CLIP from normal human brain and from mouse neurons was performed using
TAF15 antibody (Bethyl; A300-308A). HITS-CLIP and solid support directional
(SSD) RNA-seq were performed as previously described (Chi et al., 2009;
Vourekas et al., 2012). Details are found in Extended Experimental Procedures.
Peak Calling
Peaks were defined by merging overlapping tags into single merged regions
and selecting the point with the highest number of aligned reads within each
region as the actual peak position. The score of each peak was defined as
the total number of tags within the merged region.306 Cell Reports 3, 301–308, February 21, 2013 ª2013 The AuthorsCounts of Tags within Genes and Transcripts and Sample
Reproducibility
For each annotated gene and transcript, the number of tags, which are con-
tained within defined peaks, was counted. To estimate the reproducibility
among samples, the Pearson’s correlation for the gene counts for all pairwise
combinations of samples was calculated (Figure S2).
siRNA Silencing
OnDays 6 and 8 of neuronal differentiation, TAF15 knockdown was performed
using siGENOME SMART-pool (Dharmacon), with lipofectamine RNAiMax
Reagent in Opti-MEM + L-Glutamine medium (Invitrogen). Four siRNA
duplexes were used for knockdown of TAF15; sense sequences were: (a)
GGGGUGAGCAAAGUUA, (b) CCGAGGCCGUGGAGGAUAU, (c) UAGAGG
AUAUGGCGGGUCA, and (d) ACAGAAAUGAUCAGCGCAA. Cells were trans-
fected with a final concentration of 10-20 nmol siRNAs. Knockdowns with
Silencer negative control siRNA (Dharmacon) served as negative control. On
Day 9, cells were harvested for subsequent analyses.
Immunoblots and Immunoprecipitations
Cell lysate was prepared in lysis buffer (20 mM Tris-HCL (pH 7.5), 150 mM
NaCl, 2.5 mM MgCl2, 0.5% NP-40, 0.1% Triton X-100 and complete EDTA-
free protease inhibitors (Roche)). Total protein concentration was measured
using BioRad reagent per manufacturer’s instructions. Samples were
separated in 4%–12% NuPAGE gels (Invitrogen) and transferred to nitrocellu-
lose membranes (Invitrogen) for immunblotting. Quantitation of the blots was
performed with ImageJ software. Intensity ratio between different conditions
was averaged for biological triplicates per group and differences were as-
sessed using Student’s t test. For immunoprecipitations, cells were washed
with cold 13 PBS buffer, collected in RIPA buffer (0.1%SDS, 0.5%Deoxycho-
late, 1% NP-40, 150 mM NaCl, 50 mM Tris-HCl (pH 8.0)) for 15 min on ice and
centrifuged at 10,000 rpm for 10 min to obtain the soluble fractions. The total
lysate was incubated with agarose beads (Invitrogen) that were conjugated to
appropriate antibodies. Samples were processed for immunoblotting.
Antibodies
The following antibodies were used: rabbit anti-TAF15 (1:10,000; Bethyl Labo-
ratories A300-308A), mouse anti-NMDANR1 (1:1,000;Millipore 05-432), rabbit
anti-NMDAR1 Splice Variant C1 (1:1,000; Millipore AB5046P), rabbit anti-
Phospho-NMDAR1 Ser896/897 (1:1,000; EMD 454571), rabbit anti-FUS
(1:10,000; Bethyl Laboratories A300-302A-1), rabbit anti-TARDBP (I:10,000;
Protein Tech 10782-2-AP), mouse anti-FLAG M2 (1:8,000; Sigma F-3165)
and mouse anti-GAPDH (1:10,000; Sigma SAB1405848).
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